Is membranous nephropathy only a glomerular disease?

Renal Failure

Volumn 20, Issue 1, 1998, Pages 1-6

  Alexopoulos, Efstathios ^a   Papagianni, Aikaterini ^a   Papadimitriou, Menelaos ^a  

^a Aristotle University of Thessaloniki   (Greece)

Author keywords

C5b 9; Heymann Nephritis; Membranous Nephropathy; Proteinuria; Tubulointerstitial Disease

Indexed keywords

CELL PROLIFERATION; DISEASE ACTIVITY; GLOMERULOPATHY; HEYMANN NEPHRITIS; HUMAN; INTERSTITIAL NEPHRITIS; MEMBRANOUS GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; REVIEW; TARGET CELL;

EID: 0031934816     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.3109/08860229809045084     Document Type: Review

References (33)

1. Kerjaschki D. Molecular pathogenesis of membranous nephropathy: Kidney Int 41:1090-1115, 1992.
2. Pei Y, Cattran D, Greenwood C: Predicting renal insufficiency in idiopathic membranous glomerulonephritis. Kidney Int 42:960-966, 1992.
3. Ooi BS, Ooi YM, Hsu A, Hurtubise PE: Diminished synthesis of immunoglobulin by peripheral lymphocytes of patients with idiopathic membranous glomerulonephropathy. J Clin Invest 65:789-797, 1979.
4. Friend PS, Michael AF: Hypothesis: immunologic rationale for the therapy of membranous lupus nephropathy. Clin Immunol Immunopathol 10:35-40, 1978.
5. Couser WG, Stilmant MM, Darby C: Autologous immune complex nephropathy. I: Sequential study of immune complex deposition, ultrastructural changes, proteinuria and alterations in glomerular sialoprotein. Lab Invest 34:23-30, 1976.
6. Salant DJ, Darby C, Couser WG: Experimental membranous glomerulonephritis in rats. Quantitative studies of glomerular immune deposit formation in isolated glomeruli and whole animals. J Clin Invest 66:71-81, 1980.
7. Tornroth T, Skrifvars B: Gold nephropathy: prototype of membranous glomerulonephritis. Am J Pathol 75:573-586, 1984.
8. Hoorntje SJ, Weening JJ, The TH et al.: Immune-complex glomerulopathy in patients treated with captopril Lancet i:1212-1215, 1980.
9. First MR, Mendoza N, Maryniak RK, Weiss MA: Membranous glomerulopathy following kidney transplant. Transplantation 38:603-607, 1984
10. Couser WG. Pathogenesis and theoretical basis for treating membranous nephropathy. In: Davison AM, ed. Nephrology. London: Tindall, 1988:701-713.
11. Lewis EJ, Bolton WK, Spargo BA, Stuart FP: Persistent proteinuria in the rat with Heymann (autologous immune complex) nephritis. Clin Res 20:(Abstract): 763, 1972.
12. Ramzy MH, Cameron JS, Turner DR, Neild GH, Ogg CS, Hicks J: The long-term outcome of idiopathic membranous nephropathy. Clin Nephrol 16:13-19, 1981.
13. Donadio JV, Torres VE, Velosa JA et al.: Idiopathic membranous nephropathy. The natural history of untreated patients. Kidney Int 37:708-715, 1988.
14. Tornroth T, Honkanen E, Pettersson E. The evolution of membranous glomerulonephritis reconsidered: new insights from a study on relapsing disease. Clin Nephrol 28:107-117, 1987.
15. Abe S, Amagasaki Y, Konishi K, Kato E, Lyon S, Sakagushi H: Idiopathic membranous glomerulonephritis: aspects of geographical differences. J Clin Pathol 39:1193-1198, 1986.
16. Alexopoulos E, Seron D, Hartley RB, Nolasco F, Cameron JS: Immune mechanisms in idiopathic membranous nephropathy: the role of interstitial infiltrates. Am J Kidney Dis 13(5):404-412, 1989.
17. Papaghianni A: Cell-mediated immune mechanisms and the role of C5b-9 in idiopathic membranous nephropathy. MD Thesis, Thessaloniki, 1996.
18. Hutchinson FN, Kaysen GA: Albuminuria causes lysozymuria in rats with Heymann nephritis. Kidney Int 33:787-791, 1988.
19. Nath KA: Tubulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis 20:1-17, 1992.
20. Alexopoulos E, Sakellariou G, Memmos D et al : Cyclophosphamide provides no additional benefit to steroid therapy in the treatment of membranous nephropathy. Am J Kidney Dis 5:497-503, 1993.
21. Cameron JS: Tubular and interstitial factors in the progression of glomerulonephritis. Pediatr Nephrol 6:292-303, 1992.
22. Alexopoulos E: Progression of glomerulonephritis Renal Failure 18:741-753, 1996.
23. Alexopoulos E: Interstitial infiltrates in primary glomerulonephritides. In: D' Amico G, Colasanti G, eds. Issues in Nephrosciences 2.91, Milano. Wichtig Editore, 98-105, 1991.
24. Catell V: Macrophage in acute glomerular inflammation. Kidney Int 45:945-952, 1994.
25. Colten HR, Ooi YM, Edelson PJ: Synthesis and secretion of complement proteins by macrophages. Am NY Acad Sci 332:482-490, 1979
26. Broolmans RA, Stegman APA, Van Dorp WI, et al.: Interleukin 2 mediates stimulation of complement C3 biosynthesis in human proximal tubular epithelial cells. J Clin Invest 88:379-384, 1991.
27. Muller GA, Rodemann HP: Characterization of human renal fibroblasts in health and disease I. Immunophenotyping of cultured tubular epithelial cells and fibroblasts derived from kidneys with histologically proven interstitial fibrosis. Am J Kidney Dis 17:680-683, 1991.
28. Torbohm I, Schonermark M, Wingen A-M, Berger B, Rother K, Hansch GM: C5b-8 and C5b-9 modulate the collagen release of human glomerular epithelial cells Kidney Int 37.1098-1104, 1990.
29. Saito I, Atkins RC: Contribution of mononuclear leukocytes in the progression of experimental focal glomerulosclerosis. Kidney Int 37:1176-1183, 1990.
30. Bolton WK, Innes DJ, Sturgill BC, Kaiser DL: T cells and macrophages in rapidly progressive glomerulonephritis: clinicopathological correlations Kidney Int 32:869-867, 1987.
31. Arrizabalaga P, Mirapeix E, Darneli A, Revert L. Cellular immunity analysis using monoclonal antibodies in human glomerulonephritis. Nephron 53 41-49, 1989.
32. Alexopoulos E, Leontsini M, Papadimitriou M: Relationship between interstitial infiltrates and steroid-responsiveness of proteinuria m membranous nephropathy. Nephrol Dial Transplant 9:623-629, 1994.
33. Cameron JS: Membranous nephropathy: Still a treatment dilemma. N Engl J Med 327:638-639, 1992.